Industry
Elevar Hemp chosen as finalist for World CBD Awards
The brand was recognised in the Best Innovation category
Innovative wellness brand, Elevar Hemp, is celebrating having been chosen as finalist in the World CBD Awards.
The brand was recognised in the category of Best Innovations for its Elevar Leafs product, which allows CBD users to take a highly accurate dose quickly and efficiently without any cumbersome packaging, any place, any time.
The proprietary technology involves introducing specific and carefully measured quantities of water-soluble CBD to a piece of microfilm no larger than a postage stamp.
The awards recognise and reward those brands which have gone the “extra mile” in making the industry a safe and respected marketplace, showing they operate with integrity, transparency and ethical business practices.
In a statement, Elevar Hemp said: “We are privileged to have recently been nominated as a finalist in the category of Best Innovations at the World CBD Awards. While applying for the category, we leveraged our premium Elevar Leafs CBD oral strips as the key benchmark and submitted all relevant documents regarding ingredients and lab results.
“The World CBD award is a well-recognised event that takes place annually to spotlight safe, compliant and effective CBD/Hemp products, devices and services globally. The organisation focuses on identifying those who truly makes an effort in making the CBD industry a safe and respected marketplace. Nominees around the world apply for desired categories and only the top five per cent are chosen as finalists by a panel of esteemed judges made up of scientists, physicians and industry professionals.
“While we hope to be the final winner in the category, we at Elevar Hemp already feel very honoured to be chosen as a finalist, especially in the Best Innovation category.”
The winners will be announced at the awards ceremony in Barcelona on 14 July , 2022.
-
Health3 months agoCannabis linked to ‘substantial improvements’ in endometriosis symptoms
-
News4 months agoGrounding of British Airways flight sparks calls for more medical cannabis education
-
Industry4 months agoThe tipping point? UK cannabis clinics urged to clean up ‘concerning’ prescribing practices
-
Industry6 months agoLyphe UK to Launch Noidecs Vital, a New Low-Cost Medical Cannabis Line
-
News5 months agoA new centre-left government and the potential for ‘change’ in the UK cannabis landscape
-
Health6 months agoNew UK study highlights scale of illegal cannabis use for health reasons
-
Science5 months agoCBG found to reduce anxiety and enhance memory in clinical trial
-
Epilepsy2 months ago
UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For
